Saud Ahmad Al-Hokail, senior adviser at Saudi Ministry of Communications and Information Technology

Saud Ahmad Al-Hokail
Short Url
Updated 07 June 2020

Saud Ahmad Al-Hokail, senior adviser at Saudi Ministry of Communications and Information Technology

Saud Ahmad Al-Hokail has been a senior adviser on human capital at the Ministry of Communications and Information Technology (MCIT) since November 2017. 

Al-Hokail served as the director general of the human resources department at the MCIT from 2015 to 2017. He also served as the director of the human resources department at the e-government program “Yasser” from 2013 to 2017.

Prior to that, he held the position of director of the human resources department at the Saudi Human Resources Development Fund from 2006 to 2013.

Al-Hokail has previously said of his work: “The most important asset to any company are the talented human resources’ capabilities, even more important than the fixed or current assets, because they are irreplaceable and indispensable.

“Let us not forget that today’s digital age relies heavily on the human element. Therefore, organizations should build an environment conducive to the creativity and innovation of human resources.”

Al-Hokail earned his bachelor’s degree in business administration from King Saud University and completed a human resources diploma from the British Academy. He holds a certificate in KPI-A from the Strategy Management Group. 

He is a proud holder of the Gulf Cooperation Council Medal for Civil Service and Administration Development, and is a member of the Saudi Association of Administration.


Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Updated 16 January 2021

Saudi Arabia’s first COVID-19 vaccine set for clinical trials

  • It will go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority

RIYADH: Preclinical studies on the first Saudi vaccine against COVID-19 have been completed.

Professor of epidemiology Dr. Iman Almansour, who heads the team of researchers working on the vaccine at the Institute for Research and Medical Consultations (IRMC), affiliated with Imam Abdulrahman Bin Faisal University (IAU), confirmed to Arab News on Friday that the studies were complete, and said clinical trials would begin as soon as “the proper approvals” had been given.

She did not specify when that is expected to happen.

The Ministry of Education is financing the team’s project. The team’s research paper has been published in the peer-reviewed journal Pharmaceuticals.

The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen.

Dr. Iman Almansour, professor of epidemiology

According to the published paper, the vaccine has so far proven effective, when used on animals, in eliciting antibodies that will target the virus. “The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen,” Dr. Almansour explained.

Dr. Turki Almugaiteeb, director of Healthcare and Life Sciences at RPD Innovations, which runs the National Vaccine and Biomanufacturing Center, told Arab News: “There is a great focus on the results of medical research because of the pandemic. Research can play a great role in developing a vaccine that can be adopted and further developed in the future. We can say that the Kingdom has a strong infrastructure, which can help produce and manufacture a national vaccine.”

Both Almugaiteeb and Almansour stressed that the experimental vaccine will need to go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority.

Prof. Nasser Al-Aqeeli, the deputy minister of education for research and innovation, said the ministry supported programs at the Kingdom’s universities with more than SR500 million ($133.3 million) in 2020.